Recruiting

Lysosomal Storage Diseases

Sponsor:

O & O Alpan LLC

Code:

NCT02000310

Conditions

Lysosomal Storage Disorders

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The lysosome is a specialized part of the cell that functions to degrade metabolic wastes in the cell. Defects in the functioning of the lysosome result in accumulation and subsequent storage of such metabolic wastes. These defects lead to conditions known as lysosomal storage diseases (LSD). LSDs are caused by inherited genetic mutations and there are over 40 genetically distinct lysosomal storage diseases. Within each specific lysosomal storage disease there are variances in severity of disease, age of onset, and clinical presentation. Though the genetic mutations contributing to the disease have been largely clarified, the molecular and cellular mechanisms that contribute to variations in each distinct LSD remain unclear. With this study we intend to better understand at the cellular and molecular level how the accumulation and storage of metabolic wastes in the lysosome affect the clinical manifestation of LSDs, to detect changes in these mechanisms upon treatment administration, and to correlate these results to genetic information. The knowledge obtained from this research study could lead to better ways to diagnose and treat lysosomal storage diseases.

Conditions

Lysosomal Storage Disorders

Study ID

NCT02000310

Start date

Nov, 2013

Status verified date

Feb, 2021

Completion date

Dec, 2022

Anticipated

Primary completion date

Dec, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Subject is greater than or equal to 1 day of age and less than or equal to 100 years of age
  • Signed Informed Consent/Assent
  • Subject is able and willing to comply with study protocol requirements.
  • From clinical or blood laboratory findings subject has evidence of a lysosomal storage disease or a family member of a patient with lysosomal storage disease

Exclusion Criteria:

  • Pregnant woman

Study Design

Enrollment

80 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Correlating genetic mutations with clinical signs and symptoms [ Time Frame: 5 years ]

Central Contacts and Locations

Central contacts

Locations

Lysosomal and Rare Disorders Research and Treatment Center, Inc (LDRTC)

Recruiting

Fairfax, Virginia, United States, 22030

Contacts

Principal Investigator:

Ozlem Goker-Alpan, MD

More Information

Sponsor

O & O Alpan LLC

Last update posted

Feb 23, 2021

Last verified

Feb, 2021

Keywords

  • Gaucher disease
  • Fabry disease
  • Pompe disease
  • Niemann-Pick disease

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by O & O Alpan LLC on 2021-02-23.